Α-Methyldopamine

α-Methyldopamine
Clinical data
Other names	α-Me-DA; 3,4-Dihydroxyamphetamine; 3,4-DHA; HHA; 3,4-Dihydroxy-α-methylphenethylamine; 3,4-Dihydroxy-α-methyl-β-phenylethylamine; Methyldopamine; Catecholamphetamine
ATC code	None;
Identifiers
	IUPAC name 4-(2-aminopropyl)benzene-1,2-diol;
CAS Number	555-64-6 ;
PubChem CID	17005;
ChemSpider	16110 ;
UNII	XQ9A7WCY2L;
ChEBI	CHEBI:193722;
ChEMBL	ChEMBL28278 ;
CompTox Dashboard (EPA)	DTXSID00897235 ;
Chemical and physical data
Formula	C9H13NO2
Molar mass	167.208 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Oc1ccc(cc1O)CC(N)C;
	InChI InChI=1S/C9H13NO2/c1-6(10)4-7-2-3-8(11)9(12)5-7/h2-3,5-6,11-12H,4,10H2,1H3 ; Key:KSRGADMGIRTXAF-UHFFFAOYSA-N ;
	(verify)

α-Methyldopamine (α-Me-DA), also known as 3,4-dihydroxyamphetamine (3,4-DHA or HHA) or as catecholamphetamine, is a research chemical of the catecholamine and amphetamine families. It is a monoamine releasing agent and a metabolite of MDMA and MDA. The bis-glutathionyl metabolite of α-methyldopamine is slightly neurotoxic when directly injected into the brain's ventricles.